NVO — Novo Nordisk A/S stock price, charts and financials

QT53Novo Nordisk A/S

Novo Nordisk A/S (NYSE: NVO) is a Healthcare company in the Drug Manufacturers - General industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
47.73
+0.47+0.99%
OverviewShort InterestFilings
NVOQT53Novo Nordisk A/S·NYSE
47.73+0.99%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 04, 20266-KForeign issuer report
Aug 04, 20266-KForeign issuer report
Aug 04, 20266-KForeign issuer report
Jul 31, 20266-KForeign issuer report
Jul 27, 20266-KForeign issuer report
Jul 21, 20266-KForeign issuer report
Jul 13, 20266-KForeign issuer report
Jul 06, 20266-KForeign issuer report
Jun 29, 20266-KForeign issuer report
Jun 24, 20266-KForeign issuer report
Jun 22, 202611-KAnnual report (employee benefit plans)
Jun 22, 202611-KAnnual report (employee benefit plans)
Jun 22, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jun 15, 20266-KForeign issuer report
Jun 08, 20266-KForeign issuer report
Jun 01, 20266-KForeign issuer report
May 27, 20266-KForeign issuer report
May 22, 20266-KForeign issuer report
May 22, 2026SDSpecialized disclosure report
May 22, 20266-KForeign issuer report
May 18, 20266-KForeign issuer report
May 13, 20266-KForeign issuer report
May 06, 20266-KForeign issuer report
May 05, 20266-KForeign issuer report
Apr 27, 20266-KForeign issuer report
#1 / 25 of 472
Page
▼
/ 19